|
21 Companies |
|
32 Products |
|
32 Products |
|
31 Mechanisms of Action |
|
0 Trials |
|
631 News |
|
| «123456789101112 |
- || levetiracetam / Generic mfg.
New P3 trial, Monotherapy: An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy (clinicaltrials.gov) - Jan 8, 2012
P3, N=71, Active, not recruiting, Sponsor: UCB Japan Co. Ltd.
- ||| lacosamide / Generic mfg.
Enrollment change: SELF: Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure (clinicaltrials.gov) - Jan 3, 2012
P4, N=100, Completed, Sponsor: UCB, Inc.
N=200 --> 100
- |||| lacosamide / Generic mfg.
Trial completion: SELF: Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure (clinicaltrials.gov) - Jan 3, 2012
P4, N=100, Completed, Sponsor: UCB, Inc.
N=200 --> 100 Active, not recruiting --> Completed
- |||||||||| lacosamide / Generic mfg.
New P3 trial: VERVE: eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (clinicaltrials.gov) - Dec 1, 2011
P3, N=120, Completed, Sponsor: UCB, Inc.
- |||||||||| lacosamide / Generic mfg., carbamazepine / Generic mfg.
New P3 trial, Monotherapy: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older (clinicaltrials.gov) - Nov 3, 2011
P3, N=527, Recruiting, Sponsor: UCB BIOSCIENCES GmbH
- labetalol / Generic mfg.
Trial suspension: LAMPET: Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial (clinicaltrials.gov) - Oct 25, 2011
P2/3, N=8000, Suspended, Sponsor: Baylor College of Medicine
Active, not recruiting --> Completed Recruiting --> Suspended
- Diastat (diazepam rectal gel) / Bausch Health
Enrollment change: Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures (clinicaltrials.gov) - Oct 24, 2011
P2, N=358, Completed, Sponsor: University of Utah
Recruiting --> Suspended N=200 --> 358
- Clinical: Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps (clinicaltrials.gov) - Oct 23, 2011
P=N/A, N=40, Completed, Sponsor: Medical University of South Carolina
- ||||| lacosamide / Generic mfg., fosphenytoin / Generic mfg.
New P2 trial: Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures (clinicaltrials.gov) - Oct 23, 2011
P2, N=200, Recruiting, Sponsor: Aatif Husain
- ||||| Fycompa (perampanel) / Eisai, Catalyst Pharma
Enrollment closed: Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures (clinicaltrials.gov) - Oct 12, 2011
P3, N=1443, Active, not recruiting, Sponsor: Eisai Inc.
N=200 --> 358 Recruiting --> Active, not recruiting
- | New P2 trial: Stress Management Intervention for Living With Epilepsy (SMILE) (clinicaltrials.gov) - Sep 28, 2011
P2, N=100, Recruiting, Sponsor: Montefiore Medical Center
- New P1/2 trial: Animal Assisted Therapy in a Pediatric Setting (clinicaltrials.gov) - Sep 26, 2011
P1/2, N=30, Completed, Sponsor: Children's Hospitals and Clinics of Minnesota
- ||| Trial completion, HEOR: COPPER: Fitting Children With Contact Lenses (clinicaltrials.gov) - Sep 22, 2011
P=N/A, N=194, Completed, Sponsor: CIBA VISION
Recruiting --> Active, not recruiting Recruiting --> Completed
- bumetanide / Generic mfg.
New P1/2 trial: NEMO1:NEonatal Seizure Using Medication Off-patent (clinicaltrials.gov) - Sep 12, 2011
P1/2, N=49, Completed, Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust
- ||| New P3 trial, Monotherapy: Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents (clinicaltrials.gov) - Sep 8, 2011
P3, N=20, Active, not recruiting, Sponsor: GlaxoSmithKline
- | lacosamide / Generic mfg.
Trial completion: Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy (clinicaltrials.gov) - Sep 7, 2011
P2, N=49, Completed, Sponsor: UCB, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
New P4 trial: Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients (clinicaltrials.gov) - Aug 22, 2011
P4, N=100, Active, not recruiting, Sponsor: Bial - Portela C S.A.
- | Plumiaz (diazepam nasal spray) / Acorda
New P2 trial: A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode (clinicaltrials.gov) - Aug 14, 2011
P2, N=31, Completed, Sponsor: Acorda Therapeutics
- ||||||| zonisamide / Generic mfg.
Trial completion: A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures (clinicaltrials.gov) - Aug 11, 2011
P3, N=64, Completed, Sponsor: Eisai Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed